title: Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
authors.forename: O
authors.initials: O
authors.lastname: Lyytikäinen
authors.forename: E
authors.initials: E
authors.lastname: Elonen
authors.forename: I
authors.initials: I
authors.lastname: Lautenschlager
authors.forename: A
authors.initials: A
authors.lastname: Jokipii
authors.forename: L
authors.initials: L
authors.lastname: Tiittanen
authors.forename: P
authors.initials: P
authors.lastname: Ruutu
mesh_terms: D015250:Aclarubicin / Q000008:administration & dosage / Q000009:adverse effects; D000208:Acute Disease; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D011020:Pneumonia, Pneumocystis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011292:Premedication; D012189:Retrospective Studies; D013866:Thioguanine / Q000008:administration & dosage / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D015250:Aclarubicin; D003907:Dexamethasone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003520:Cyclophosphamide; D008942:Mitoxantrone; D015122:Mercaptopurine; D013866:Thioguanine; D002330:Carmustine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin